Literature DB >> 3982655

Incidence and prevalence of tuberous sclerosis in Rochester, Minnesota, 1950 through 1982.

W C Wiederholt, M R Gomez, L T Kurland.   

Abstract

The incidence of tuberous sclerosis in Rochester, MN, was 0.56 per 100,000 person-years in 1950 through 1982, and point prevalence on December 31, 1980, was 10.6 per 100,000 persons. The true incidence and prevalence may be even higher, because cases with hypomelanotic macules and no other clinical manifestations are often unrecognized. Pertinent clinical observations in the eight cases identified included familial occurrence in two; hypomelanotic macules in all eight; seizures with onset before age 2 in four, of whom two were mentally retarded; and no neurologic abnormalities in those free of seizures.

Entities:  

Mesh:

Year:  1985        PMID: 3982655     DOI: 10.1212/wnl.35.4.600

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  21 in total

1.  Evidence for genetic heterogeneity in tuberous sclerosis: one locus on chromosome 9 and at least one locus elsewhere.

Authors:  H Northrup; D J Kwiatkowski; E S Roach; W B Dobyns; R A Lewis; G E Herman; E Rodriguez; S P Daiger; S H Blanton
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

2.  Insulinoma complicating tuberous sclerosis.

Authors:  P M Davoren; M T Epstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

3.  Report of a critical recombination further narrowing the TSC1 region.

Authors:  K S Au; J Murrell; A Buckler; S H Blanton; H Northrup
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

4.  Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients.

Authors:  K S Au; J A Rodriguez; J L Finch; K A Volcik; E S Roach; M R Delgado; E Rodriguez; H Northrup
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

5.  Genetic aspects of tuberous sclerosis in the west of Scotland.

Authors:  J R Sampson; S J Scahill; J B Stephenson; L Mann; J M Connor
Journal:  J Med Genet       Date:  1989-01       Impact factor: 6.318

Review 6.  Tuberous sclerosis.

Authors:  D W Webb; J P Osborne
Journal:  Arch Dis Child       Date:  1995-06       Impact factor: 3.791

7.  Autism and tuberous sclerosis complex: prevalence and clinical features.

Authors:  P Baker; J Piven; Y Sato
Journal:  J Autism Dev Disord       Date:  1998-08

Review 8.  Anti-epileptogenic clinical trial designs in epilepsy: issues and options.

Authors:  Dieter Schmidt; Daniel Friedman; Marc A Dichter
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

9.  Localization of one gene for tuberous sclerosis within 9q32-9q34, and further evidence for heterogeneity.

Authors:  J L Haines; M P Short; D J Kwiatkowski; A Jewell; E Andermann; B Bejjani; C H Yang; J F Gusella; J A Amos
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

10.  On the incidence of fits and mental retardation in tuberous sclerosis.

Authors:  D W Webb; A E Fryer; J P Osborne
Journal:  J Med Genet       Date:  1991-06       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.